First Time Loading...

Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 3 064 JPY -0.49% Market Closed
Updated: May 5, 2024
Section:
 

Relative Value

The Relative Value of one Rohto Pharmaceutical Co Ltd stock under the Base Case scenario is 2 863.73 JPY. Compared to the current market price of 3 064 JPY, Rohto Pharmaceutical Co Ltd is Overvalued by 7%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
2 863.73 JPY
Overvaluation 7%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.7
P/S
P/S
Price to Sales
2.7
vs History
38
vs Industry
19
Median 3Y
2.9
Median 5Y
2.3
Industry
1.1
Forward
2.6
More Details
22.6
P/E
P/E
Price to Earnings
22.6
vs History
76
vs Industry
25
Median 3Y
26
Median 5Y
27.2
Industry
17.9
Forward
22.3
More Details
24.4
P/OCF
P/OCF
Price to OCF
24.4
vs History
31
vs Industry
14
Median 3Y
24.5
Median 5Y
20.9
Industry
11.4
More Details
61
P/FCFE
P/FCFE
Price to FCFE
61
vs History
14
vs Industry
8
Median 3Y
57.7
Median 5Y
32.2
Industry
16.8
More Details
2.9
P/B
P/B
Price to Book Value
2.9
vs History
39
vs Industry
20
Median 3Y
3.3
Median 5Y
2.7
Industry
1.6
More Details
2.4
EV/S
EV/S
Enterprise Value to Sales
2.4
vs History
38
vs Industry
23
Median 3Y
2.6
Median 5Y
2.1
Industry
1.2
Forward
2.3
More Details
4.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.1
vs History
39
vs Industry
42
Median 3Y
4.5
Median 5Y
3.6
Industry
3.9
More Details
12.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.9
vs History
41
vs Industry
27
Median 3Y
14.8
Median 5Y
11.9
Industry
10.5
Forward
12.4
More Details
15.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
15.3
vs History
50
vs Industry
28
Median 3Y
18.2
Median 5Y
15.3
Industry
13.6
More Details
21.7
EV/OCF
EV/OCF
Enterprise Value to OCF
21.7
vs History
31
vs Industry
17
Median 3Y
21.9
Median 5Y
18.6
Industry
11.6
More Details
32.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
32.8
vs History
33
vs Industry
13
Median 3Y
33.3
Median 5Y
30.1
Industry
14.7
More Details
2.6
EV/IC
EV/IC
Enterprise Value to IC
2.6
vs History
39
vs Industry
21
Median 3Y
2.9
Median 5Y
2.3
Industry
1.3
More Details

Multiples Across Competitors

Competitors Multiples
Rohto Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Rohto Pharmaceutical Co Ltd
TSE:4527
699B JPY 2.7 22.6 12.9 15.3
FR
L'Oreal SA
PAR:OR
235.8B EUR 5.7 38.1 25.3 30.9
UK
Unilever PLC
LSE:ULVR
104.7B GBP 2 18.8 197.8 229.2
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.2T INR 8.4 50.5 34.6 37.6
US
Estee Lauder Companies Inc
NYSE:EL
47.6B USD 3.1 102 27.4 48.3
UK
HALEON PLC
LSE:HLN
30.5B GBP 2.7 29 13.6 15.2
DE
Beiersdorf AG
XETRA:BEI
32.5B EUR 3.4 44.1 16.7 22.2
JP
Kao Corp
TSE:4452
3T JPY 2 69.3 16.9 34.4
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR 9.2 71.8 42.1 46.2
IN
Dabur India Ltd
NSE:DABUR
942.1B INR 7.7 52.5 40 47.6
JP
Shiseido Co Ltd
TSE:4911
1.7T JPY 1.8 78.4 19.1 93.6

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.